Peconic Partners’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Peconic Partners’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-222,965	Closed	-$4.17M	–	57
2018 Q3	$4.17M	Sell	222,965 -474,035	-68%	-$10.9M	1.05%	10
2018 Q2	$18M	Buy	697,000 +28,500	+4%	+$740K	3.31%	5
2018 Q1	$15M	Buy	668,500 +20,252	+3%	+$494K	2.9%	6
2017 Q4	$16.2M	Buy	648,248 +548,248	+548%	+$13.4M	2.33%	9
2017 Q3	$2.42M	Buy	+100,000	New	+$2.35M	0.39%	18

Other funds holding FLXN

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Peconic Partners's FLXN Position: Q4 2018 in Review

Peconic Partners sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2018, closing a stake of 222,965 shares — an estimated $4.17M sold.

Peconic Partners first reported a position in FLXN in Q3 2017 and held it in 5 quarters. The position peaked at $18M in Q2 2018. 125 funds tracked by Wall St. Rank hold FLXN as of Q4 2018.

Peconic Partners reported no remaining Flexion Therapeutics, Inc. position as of Q4 2018 after selling out during the quarter.
Peconic Partners sold 222,965 Flexion Therapeutics, Inc. shares in Q4 2018, an estimated $4.17M.
Peconic Partners first reported a position in Flexion Therapeutics, Inc. in Q3 2017 and held it in 5 quarters.
Peconic Partners's Flexion Therapeutics, Inc. position peaked at $18M in Q2 2018.
125 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2018.

Based on Peconic Partners's 13F filing for Q4 2018, filed 14 Feb 2019.